Highlights in Hodgkin Lymphoma From the 63rd American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the 63rd ASH Meeting and Exposition December 11-14, 2021 • Atlanta, Georgia Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced-Stage […]

Chimeric Antigen Receptor T-Cell Therapy Targeting CD30 in Hodgkin Lymphoma

H&O What prompted your research of chimeric antigen receptor (CAR) T-cell therapy in Hodgkin lymphoma? BS It has been known for a long time that Hodgkin […]

Highlights in Hodgkin Lymphoma From the 61st American Society of Hematology Annual Meeting

A Review of Selected Presentations From the 61st ASH Meeting • December 7-10, 2019 • Orlando, Florida Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab […]

Surveillance Scanning in Lymphoma

Abstract: Although the role of imaging in the management of most lymphomas is well established at baseline, during treatment, and following treatment, surveillance imaging after […]